GZMB and rheumatoid arthritis: The higher CD107a−/CD107a+ ratio in RA patients, representing the ratio of nondegranulating GzmB+ cells to the degranulating subset, suggests a defect in the release of cytotoxic granules by CD27−CD28− CD4+ T cells (Figure 6C).